SHEZF (Shenzhen Hepalink Pharmaceutical Group Co) Tariff Resilience Score: 0/10 (As of Jul. 08, 2026)


SHEZF Shenzhen Hepalink Pharmaceutical Group Co Ltd SHEZF
70 GF Score
Price $0.47
GF Value $0.56
! 7 Warning Signs
View Full Analysis

What is Shenzhen Hepalink Pharmaceutical Group Co Tariff Resilience Score?

Shenzhen Hepalink Pharmaceutical Group Co has the Tariff Resilience Score of 0, which implies that the company might have .

Shenzhen Hepalink Pharmaceutical Group Co has

Tariff Resilience Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more.

The company's exposure to international trade tariffs based on these criteria:

1. Global supply chain dependencies
2. Manufacturing locations versus sales markets
3. Import/export balance and percentage of revenue
4. Historical impact from previous tariff changes
5. Available mitigation strategies (alternative suppliers, pricing power)
6. Industry-specific tariff exemptions or vulnerabilities

Based on the research, GuruFocus believes Shenzhen Hepalink Pharmaceutical Group Co might have .

Shenzhen Hepalink Pharmaceutical Group Co  (OTCPK:SHEZF) Tariff Resilience Score Explanation

The Tariff Resilience Score ranges from 0 to 10, with 10 as the most resilient. GuruFocus divided Moat Score into following 3 categories:

Tariff Resilience Score Resilience Level
7 - 10Highly Resilient
4 - 6Average Resilient
0 - 3Highly Vulnerable

Shenzhen Hepalink Pharmaceutical Group Co Tariff Resilience Score Related Terms

SHEZF
70GF Score
Shenzhen Hepalink Pharmaceutical Group Co Ltd SHEZF
Tariff Resilience Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Shenzhen Hepalink Pharmaceutical Group Co (SHEZF) Overvalued in 2026?

Based on GuruFocus' analysis, Shenzhen Hepalink Pharmaceutical Group Co stock appears to be undervalued. The current stock price of $0.47 is trading 16.1% below its estimated GF Value™ of $0.56.

Key valuation signals for SHEZF:

  • Tariff Resilience Score: 0
  • GF Value™: $0.56 vs. price of $0.47 (16.1% below fair value)
  • GF Score™: 70/100 with 7 warning signs

No single metric tells the full story. See the SHEZF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Shenzhen Hepalink Pharmaceutical Group Co Business Description

Other Exchanges 09989:Hong Kong002399:China
Address No. 21 Langshan Road, Songping Mountain, Guangdong Province, Nanshan District, Shenzhen, CHN, 518057
Shenzhen Hepalink Pharmaceutical Group Co Ltd is a China-based company. Along with its subsidiary, it is engaged in biopharmaceutical production, biopharmaceutical services, biopharmaceutical trading, and biopharmaceutical research and development in Asia, Europe, North America, and Australia, and investment business in Asia and North America. The Group mainly operates three main business segments, including the Finished dose pharmaceutical products; Active pharmaceutical ingredients; CDMO business; and Others. The geographical presence of the company is in Hong Kong, the United States of America, Europe, Mainland China, and Other countries. The majority of the company's revenue comes from Europe and the USA.
70GF Score

Get the complete analysis for SHEZF

Tariff Resilience Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.47
Price
$0.56
GF Value